Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westbrook, V. A.
Right arrow Articles by Herr, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westbrook, V. A.
Right arrow Articles by Herr, J. C.
Clinical Cancer Research Vol. 10, 101-112, January 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell Lines

V. Anne Westbrook1, Pamela D. Schoppee1, Alan B. Diekman1, Kenneth L. Klotz1, Margaretta Allietta1, Kevin T. Hogan2, Craig L. Slingluff2, James W. Patterson3, Henry F. Frierson3, William P. Irvin, Jr.4, Charles J. Flickinger1, Michael A. Coppola1 and John C. Herr1

1Departments of Cell Biology,2 Surgery,3 Pathology, and4 Obstetrics and Gynecology, Center for Research in Contraceptive and Reproductive Health, University of Virginia, Charlottesville, Virginia

Purpose: Members of the SPAN-X (sperm protein associated with the nucleus mapped to the X chromosome) family of cancer-testis antigens are promising targets for tumor immunotherapy because they are normally expressed exclusively during spermiogenesis on the adluminal side of the blood-testis barrier, an immune privileged compartment.

Experimental Design and Results: This study analyzed the human SPANX genomic organization, as well as SPAN-X mRNA and protein expression in somatic and cancer cells. The SPANX family consists of five genes, one of which is duplicated, all located in a gene cluster at Xq27.1. From the centromere, the arrangement of the five SPANX genes mapped on one contiguous sequence is SPANXB, -C, -A1, -A2, and -D. Reverse transcription-PCR analyses demonstrated expression of SPAN-X mRNA in melanoma and ovarian cell lines, and virtual Northern analysis established SPANX gene expression in numerous cancer cell lines. Immunoblot analysis using polyclonal antisera raised against recombinant SPAN-X confirmed the translation of SPAN-X proteins in melanoma and ovarian tumor cell lines. The immunoreactive proteins migrated between Mr 15,000 and Mr 20,000 similar to those observed in spermatozoa. Immunoperoxidase labeling of melanoma cells and tissue sections demonstrated SPAN-X protein localization in the nucleus, cytoplasm, or both. Ultrastructurally, in melanoma cells with nuclear SPAN-X, the protein was associated with the nuclear envelope, a localization similar to that observed in human spermatids and spermatozoa. Significantly, the incidence of SPAN-X-positive immunostaining was greatest in the more aggressive skin tumors, particularly in distant, nonlymphatic metastatic melanomas.

Conclusions: The data herein suggest that the SPAN-X protein may be a useful target in cancer immunotherapy.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. Luo, X. Xiao, D. Liu, S. Chen, M. Li, A. Xu, J. Liu, S. Gao, S. Wu, and D. He
CABYR Is a Novel Cancer-Testis Antigen in Lung Cancer
Clin. Cancer Res., February 15, 2007; 13(4): 1288 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
V.A. Westbrook, P.D. Schoppee, G.R. Vanage, K.L. Klotz, A.B. Diekman, C.J. Flickinger, M.A. Coppola, and J.C. Herr
Hominoid-specific SPANXA/D genes demonstrate differential expression in individuals and protein localization to a distinct nuclear envelope domain during spermatid morphogenesis
Mol. Hum. Reprod., November 1, 2006; 12(11): 703 - 716.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
N. Kouprina, A. Pavlicek, V. N. Noskov, G. Solomon, J. Otstot, W. Isaacs, J. D. Carpten, J. M. Trent, J. Schleutker, J. C. Barrett, et al.
Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27
Genome Res., November 1, 2005; 15(11): 1477 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Kouprina, M. Mullokandov, I. B. Rogozin, N. K. Collins, G. Solomon, J. Otstot, J. I. Risinger, E. V. Koonin, J. C. Barrett, and V. Larionov
The SPANX gene family of cancer/testis-specific antigens: Rapid evolution and amplification in African great apes and hominids
PNAS, March 2, 2004; 101(9): 3077 - 3082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.